Outsourcing on the Rise
En vogue and in demand, the industry’s reliance on CDMOs is growing
Maryam Mahdi | | Interview
With full pipelines and delivery times stretching well into the distant future, CDMOs are being called upon by pharma companies with increasing frequency to meet process development and manufacturing demands. Denis Geffroy, VP of Business Development, and Professor Tom Moody, VP Technology Development and Commercialisation, both at Almac Sciences, give their perspectives on the issue – and how the CDMO sector is shaping up to handle increased workloads.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.